Surgery News and Research

RSS

NewHope Bariatrics Surgery Center receives AAAHC accreditation certificate

NewHope Bariatrics Surgery Center announced today that its new bariatric-focused surgery center in The Colony has received accreditation from the Accreditation Association for Ambulatory Health Care, Inc.

27 Jan 2010

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The

27 Jan 2010

Joint Commission urges hospitals to take steps to prevent pregnancy-related deaths

Pre-existing medical conditions such as high blood pressure are putting women at greater risk for death during or shortly after pregnancy, according to a Joint Commission Sentinel Event Alert issued today.

27 Jan 2010

Mayo Clinic teams up with PCH to provide surgical treatment for patients with PE

Mayo Clinic is teaming up with Phoenix Children's Hospital (PCH) and Pediatric Surgeons of Phoenix to provide comprehensive surgical treatment to both children and adults with pectus deformities.

27 Jan 2010

MAQUET Cardiovascular initiates study evaluating EVH in CABG compared to open vein harvesting

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced the initiation of the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) study. This clinical trial is designed to evaluate the equivalence of Endoscopic Vessel Harvesting (EVH) in Coronary Artery Bypass Graft (CABG) surgery compared with historical data for open vein harvesting. David Moore, M.D., of THE HEART HOSPITAL Baylor Plano is the principal investigator for the OPTION trial.

27 Jan 2010

Discovery challenges understanding of blood cell development

University of Utah researchers led an international team of scientists that is the first to report on the previously undescribed ability of platelets to reproduce themselves in the circulation. Their revolutionary findings were published online Jan. 19, 2010, in the journal Blood.

27 Jan 2010

Genome study could help prevent devastating epidemics in the future

A team of collaborating scientists at The Methodist Hospital Research Institute in Houston, the Broad Institute in Boston, Mount Sinai Hospital in Toronto, and the Ontario Agency for Health Protection and Promotion (OAHPP) have sequenced almost 100 full genomes from three successive epidemics of flesh-eating bacteria.

27 Jan 2010

Update on Cardium Therapeutics' plans for commercial development of Generx

Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.

27 Jan 2010

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.

27 Jan 2010

Ablation therapy better than drug therapy for heart rhythm disorder

Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Medical Association (JAMA).

27 Jan 2010

Selective use of DHCA during surgery for CHD in infancy does not impair neurological outcomes

Congenital heart defects (CHD) are the most common birth defects in humans, affecting 8 per 1000 live births with one third of affected children requiring intervention in early infancy. Increasing numbers of survivors combined with developmental expectations for independence, behavioral self-regulation and academic achievement have led to a growing identification of neurobehavioral symptoms in some survivors. A study now suggests that a cooling technique often used in heart operations does not impair neurological outcomes.

27 Jan 2010

Study finds regional hospitals often are better at preventing medical errors than academic centers

Some regional hospitals perform better than academic medical centers at preventing complications and infections that can lead to hospital deaths, Forbes reports. The article looks at the results of an annual study by HealthGrades, a hospital rating company, of Medicare data which found 269 hospitals around the country "with unusually low mortality and complications rates for 26 different procedures and diagnoses."

27 Jan 2010

OrthoPediatrics to distribute ETEX products in U.S. and Canada

ETEX Corporation, an advanced biomaterials company, announced today a distribution agreement with OrthoPediatrics Corp., of Warsaw, Indiana. OrthoPediatrics will market and sell ETEX's nanocrystalline calcium phosphate on a non-exclusive basis in the United States and Canada.

27 Jan 2010

Neoprobe completes license amendment with The Dow Chemical

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has completed a license amendment with The Dow Chemical Company for a variety of antibodies used in its proprietary surgical oncology system called radioimmunoguided surgery or RIGS®.

27 Jan 2010

Medtronic' Melody Transcatheter Pulmonary Valve receives FDA approval under HDE

In a significant development for congenital heart disease patients, Medtronic, Inc. (NYSE: MDT), announced today that its Melody® Transcatheter Pulmonary Valve has received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE).

27 Jan 2010

Testing DBS for treating severe long-term depression

Bewernick and colleagues administered DBS treatment in ten patients with severe long-term depression who had not responded to multiple other antidepressant treatments, including psychotherapy, drug treatments and electroconvulsive treatment. After one year of DBS, all patients showed some improvement, and half of them experienced significant improvement in their symptoms of depression, astonishing considering they had not responded to any prior antidepressant treatment. In addition, the patients showed reduced ratings of anxiety and had only minor side effects. Importantly, none of their overall brain functioning was impaired by the DBS treatment.

27 Jan 2010

FDA approves first heart valve conduit that can delay need for open-heart surgery

The U.S. Food and Drug Administration today approved the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System, the first heart valve to be implanted through a catheter, or tube, in a leg vein and guided up to the heart. This new approach to the treatment of adults and children with previously implanted, poorly functioning pulmonary valve conduits can delay the need for open-heart surgery.

27 Jan 2010

Long-term graft retention is improved through supplementation of fat grafts with ADRCs

Results from Cytori Therapeutics’ preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled “Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention,” examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement.

25 Jan 2010

First commercial implants of ATS Medical's ATS 3f Enable Aortic Bioprosthesis performed

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced the first commercial implants of the ATS 3f Enable® Aortic Bioprosthesis were recently performed at the University of Berne Hospital, Berne, Switzerland by Lars Englberger, MD, Mario Stalder, MD, and Professor Thierry Carrel. The procedures were completed using a sutureless technique and the patients are recovering with no complications.

25 Jan 2010

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

The Institute of Medicine, a branch of the US National Academy of Sciences, is urging healthcare providers to take steps to battle liver-damaging hepatitis B and C, which are often overlooked viruses.

25 Jan 2010

Surgery News and Research

NewHope Bariatrics Surgery Center receives AAAHC accreditation certificate

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

Joint Commission urges hospitals to take steps to prevent pregnancy-related deaths

Mayo Clinic teams up with PCH to provide surgical treatment for patients with PE

MAQUET Cardiovascular initiates study evaluating EVH in CABG compared to open vein harvesting

Discovery challenges understanding of blood cell development

Genome study could help prevent devastating epidemics in the future

Update on Cardium Therapeutics' plans for commercial development of Generx

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Ablation therapy better than drug therapy for heart rhythm disorder

Selective use of DHCA during surgery for CHD in infancy does not impair neurological outcomes

Study finds regional hospitals often are better at preventing medical errors than academic centers

OrthoPediatrics to distribute ETEX products in U.S. and Canada

Neoprobe completes license amendment with The Dow Chemical

Medtronic' Melody Transcatheter Pulmonary Valve receives FDA approval under HDE

Testing DBS for treating severe long-term depression

FDA approves first heart valve conduit that can delay need for open-heart surgery

Long-term graft retention is improved through supplementation of fat grafts with ADRCs

First commercial implants of ATS Medical's ATS 3f Enable Aortic Bioprosthesis performed

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News